Search Results 541-550 of 19233 for hemoglobin

1. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

   Hemoglobin < 10 g/dL; Platelets < 25,000 cells per mm3; Total bilirubin > 3.0 mg/dL. Participating Mayo Clinic locations. Study statuses change often. Please ...

2. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   Hemoglobin ≥ 8 g/dL. Biochemistry: Total Bilirubin within normal institutional limits. AST/SGOT and ALT/SGPT ≤ 2.5 x upper limit of normal (ULN), except ...

3. A Study to Evaluate the Effect of GBT440 on Oxygenation in Healthy Subjects, both at Rest and at Maximal Exercise - Mayo Clinic

   Hemoglobin value of < 11 or > 17 mg/dL; ECG with a QTcF ≥ 430 ms (males) or QTcF ≥ 450 ms (females); Family or personal history of congenital long QT ...

4. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

   Hemoglobin > 85 g/L and platelet count > 150 x 10^9/L at Screening. Part B Inclusion Criteria: 1. Has the ability to provide informed consent, and has an ...

5. Muscle and Adipose Trafficking of Fatty Acids Under Hypoinsulinemic and Fed Conditions - Mayo Clinic

   Normal hemoglobin >11.0 g/dL for women and men will be acceptable. Women of child-bearing potential will complete a urine pregnancy test at each visit.

6. A Study to Evaluate Tranexamic Acid (TXA) Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection - Mayo Clinic

   Severe anemia (hemoglobin (Hgb) levels <90 g/l). Documented arterial or venous thrombosis at screening or in past three months (not including therapeutic ...

7. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases - Mayo Clinic

   Hemoglobin ≥ 10 g/dL*; allowing transfusion or other intervention to achieve this minimum hemoglobin; BUN < 30 mg/dL; Creatinine < 1.7 mg/dL; Bilirubin ≤ 2.0 ...

8. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); Aspartate transaminase (AST); alanine aminotransferase (ALT) ...

9. Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes - Mayo Clinic

   Phase I/II: Patients must have received ≥ 2 units of RBCs for hemoglobin ≤ 9.0 g/dL within 8 weeks prior to start of treatment. Patient is non-responsive ...

10. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) \< 45 mL/min/1.73m\^2 Hemoglobin (Hgb) concentration \< 8.5 g/dL at Screening. 19. Evidence of active or latent ...